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Abstract  27 
 28 
Among 64 uropathogenic Escherichia coli (UPEC) isolated from 13 cats and 51 dogs, 35 29 
were extended-spectrum beta-lactamase (ESBL) producers, and 29 were non-ESBL producers. 30 
Forty-six (71.9%) of the isolates were multidrug resistant (MDR). Among the ESBL 31 
producers, blaCTX-M-15 (n=17/48.6% of the blaESBLs), blaCTX-M-1 (n=10/28.6%), blaCTX-M-55 32 
(n=4/11.4%), blaCTX-M-14 (n=3/8.6%), and blaCTX-M-27 (n=1/2.9%) were identified. The 33 
plasmid-mediated fluoroquinolone resistance genes aac(6')-Ib-cr, qnrB and the azithromycin 34 
resistance gene mph(A) were detected in 17 (26.6% of all isolates), one (1.6%) and in 13 35 
(20.3%) respectively. The most frequent phylogenetic groups were C (n=19) and B2 (n=15). 36 
Twenty-six different sequence types (STs) were identified, with two being novel. The most 37 
frequent STs were ST410 (n=16/25%), ST131, and ST73 (both n=5/7.8%), and ST361 38 
(n=4/6.3%). Ten (15.6%) of the STs have been associated with urinary tract infection (UTI) in 39 
humans, suggesting zoonotic potential. Among seven virulence-associated genes, fyuA was 40 
the most prevalent. The overall aggregate virulence factor (VF) score was highest for isolates 41 
belonging to phylogenetic group B2 (median aggregate VF score 6, mean score 5,5, range 3-42 
7), and lowest for isolates belonging to phylogenetic group C (0/ 0.5/0-3). The most frequent 43 
ST in this study, ST410, harboured the lowest number of VF (0/0,3/0-2).  44 
VF scores were higher in NDR (4/3.8/3-4) than in MDR (1/1,9/0-7), and higher in non-ESBL 45 
producing isolates (3/3/0-7) than in ESBL producers (1/1,7/0-7). Our data advance our 46 
knowledge of the phenotypic and genotypic characteristics of UPEC in companion animals 47 
and their potential for infection, zoonotic transmission and dissemination of antimicrobial 48 
resistance determinants.  49 
 50 
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1. Introduction 53 
 54 
Escherichia coli occurs naturally in the digestive tract of humans and animals as a commensal, 55 
however, some strains of E. coli can cause extraintestinal diseases, such as pneumonia, sepsis, 56 
meningitis and urinary tract infections (UTI) (Kaper et al., 2004).  57 
Commensal strains have been shown by phylogenetic analyses to be associated with 58 
phylogenetic group A, B1 or C, while virulent extraintestinal E. coli strains belong mainly to 59 
group B2 and, to a lesser extent, to group D, E, or F (Clermont et al., 2013). 60 
Uropathogenic E. coli (UPEC) is the most common etiologic agent of UTI in humans and 61 
animals (Foxman, 2010; Olin and Bartges, 2015). The ability of UPEC to cause disease is 62 
associated with the expression of specific virulence factors (VF) encoding adhesins, invasins, 63 
toxins and other proteins (Kaper et al., 2004).  64 
Among companion animals, E. coli clones that are found in the intestine may cause urinary 65 
tract infection (UTI) (Johnson et al., 2008b). Furthermore, UPEC may be acquired via 66 
external reservoirs: previous studies have demonstrated that humans and their companion 67 
animals can share pathogenic types of E. coli, including UPEC, indicating zoonotic as well as 68 
anthroponotic transmission (Johnson et al., 2008b; Johnson et al., 2008c; Johnson et al., 2009). 69 
Other significant sources of pathogenic E. coli include raw meat canine diets and raw or 70 
inadequately cooked chicken meat (Glaser 2012; Schmidt et al., 2015).  71 
For uncomplicated UTI in cats and dog, the first-line therapeutic option is amoxicillin, with 72 
sulfamethoxazole/trimethoprim and fluoroquinolones remaining appropriate for complicated 73 
infections and pyelonephritis, respectively (Barsanti, 2012). The emergence of antimicrobial 74 
resistance among UPEC is of great concern and increases the risk of antimicrobial treatment 75 
failure in companion animals, as in humans.  76 
Understanding the prevalence of antimicrobial resistance and pathogenicity of UPEC isolated 77 
from cats and dogs is important both from veterinary medicine and public health perspectives, 78 
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but information regarding the population structure and virulence association of UPEC from 79 
cats and dogs is still limited. 80 
The aim of this study was therefore to (i) assess the antimicrobial susceptibility of 81 
uropathogenic E. coli isolates obtained throughout 2012–2016 from Swiss dogs and cats, (ii) 82 
to detect and characterize plasmid-mediated resistance to third-generation cephalosporins, 83 
fluoroquinolones and azithromycin, (iii) to characterize the strains by phylogenetic grouping, 84 
multilocus sequence typing (MLST) and virulence profiling. 85 
 86 
2. Materials and Methods 87 
 88 
2.1. Bacterial isolates 89 
 90 
From a total of 205 Escherichia coli strains isolated between 2012 and 2016 from urine 91 
samples of companion animals admitted to the University of Zürich veterinary clinic, a total 92 
of 64 (35 ESBL-producing and 29 randomly selected non-ESBL producing) strains from 13 93 
cats and 51 dogs were analysed. Strain identification and preliminary antimicrobial 94 
susceptibility profiling was performed using VITEK 2 Compact system with AST GN38 95 
cards (Biomérieux, Marcy l’Etoile, France) according to the manufacturer’s instructions. 96 
 97 
2.2. Phenotypic and genotypic antimicrobial resistance testing 98 
 99 
Antimicrobial susceptibility testing was performed using the disk-diffusion method and the 100 
antibiotics ampicillin (AM), cefazolin (CZ), cefotaxime (CTX), amoxicillin with clavulanic 101 
acid (AMC), cefepime (FEP), nalidixic acid (NA), ciprofloxacin (CIP), 102 
sulfamethoxazole/trimethoprim (SXT), fosfomycin (FOS), nitrofurantoin (F/M), streptomycin 103 
(S), kanamycin (K), gentamicin (G), chloramphenicol (C) and tetracycline (TE) (Becton 104 
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Dickinson, Allschwil, Switzerland). Results were interpreted according to Clinical and 105 
Laboratory Standards Institute (CLSI) performance standards (CLSI, 2016). Isolates 106 
displaying resistance to three or more classes of antimicrobials (counting beta-lactams as one 107 
class) were defined as multidrug-resistant (MDR). Synergistic effects between AMC and 108 
CTX and FEP were regarded as an indication of the presence of an ESBL producer (Kaur et 109 
al., 2013). 110 
For genotypic analyses, bacterial DNA was extracted using a standard heat lysis protocol. The 111 
presence of blaESBL genes belonging to the blaTEM, blaSHV, and blaCTX-M families was 112 
confirmed by PCR and amplicons were sequenced as described previously (Woodford et al., 113 
2006; Zurfluh et al., 2015). Ciprofloxacin resistant strains were examined for mutations in 114 
quinolone resistance-determining regions (QRDRs) of gyrA and parC, using previously 115 
described PCR and sequencing primers (Zurfluh et al., 2014). Screening all isolates for the 116 
plasmid-mediated fluoroquinolone resistance genes aac(6')-Ib-cr, qnrA, qnrB, qnrC, qnrD, 117 
qnrS, and qepA was carried out as described previously (Zurfluh et al., 2014). Further, all 118 
strains were screened for the plasmid-mediated azithromycin resistance gene mph(A) using 119 
previously described primers (Ojo et al., 2004). DNA samples from isolates described 120 
previously were used as positive controls (Nüesch-Inderbinen et al., 2017; Zurfluh et al., 121 
2014). 122 
Synthesis of primers and DNA custom sequencing was carried out by Microsynth (Balgach, 123 
Switzerland) and nucleotide sequences were analysed with CLC Main Workbench 6.6.1. For 124 
database searches the BLASTN program of NCBI (http://www.ncbi.nlm.nih.gov/blast/) was 125 
used.  126 
 127 
2.3. Phylogenetic characterization and multilocus sequence typing 128 
 129 
The distribution of phylogenetic groups amongst the isolates was determined by the  130 
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improved phylotyping PCR approach described by Clermont et al., targeting the genes chuA, 131 
yjaA, arpA and TspE4.C2 (Clermont et al., 2013). Isolates were thereby classified as 132 
belonging to one of the eight phylogenetic groups A, B1, B2, C, D, E, F, (E. coli sensu 133 
stricto), or Escherichia clade I. 134 
For multilocus sequence typing of E. coli isolates, internal fragments of the seven 135 
housekeeping genes (adk, fumC, gyrB, icd, mdh, purA, and recA) were amplified by PCR 136 
from DNA, as described by Wirth et al. (Wirth et al., 2006). Sequencing of the amplification 137 
products was performed by Microsynth (Balgach, Switzerland). Sequences were imported 138 
into the E. coli MLST database website (http://mlst.ucc.ie/mlst/dbs/Ecoli) to determine 139 
sequence types (STs). Alleles and STs that had not been previously described were designated 140 
new ST, but not assigned numerical designations, since whole-genome sequencing was not 141 
performed. 142 
 143 
2.4. Virulence factor (VF) determination 144 
 145 
All 64 strains were tested by conventional PCR for the presence of genes of VF that mediate 146 
adhesion (p-fimbrial adhesion genes papAH and papEF, and the chaperone-usher fimbria 147 
yfcv), toxins (a-haemolysin hlyA), siderophores (the ferric yersiniabactin uptake protein fyuA), 148 
serum resistance (traT), and the right-hand terminus of pathogenicity island (PAI) from E. 149 
coli strain CFT073, using primers and conditions described previously (Johnson and Stell, 150 
2000; Spurbeck et al., 2012). The aggregate VF score was defined as the number of unique 151 
VF detected for each isolate, counting the PAI marker as one. 152 
 153 	  154 
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2.5 eBURST 155 
 156 
The Based Upon Related Sequence Types (eBURST) clustering algorithm in phyloviz 157 
(www.phyloviz.net) was used to visualise relationships between the isolates. 158 
 159 
3. Results 160 
 161 
3.1. Antimicrobial resistance 162 
 163 
Between 2012-2016, 205 E. coli strains were collected (41 in 2012, 121 in 2013, 17 in 2014, 164 
17 in 2015 and 9 in 2016). During these years, ESBL producers were detected in 10 (24.4%), 165 
12 (9.9%), 4(23.5%), 6 (35.3%), and 3 (33.3%) of the isolates, respectively. Resistance 166 
profiles of the 35 ESBL producing and 29 non-ESBL producing isolates to all 15 167 
antimicrobials tested are shown in detail in supplementary Table S1. Resistance rates to 168 
classes of antimicrobials commonly used for treating feline and canine E. coli UTIs are 169 
summarized in Table 1. 170 
Overall, 46 (71.9%) of the isolates were MDR (88.6% of the ESBL-producers, and 51.7% of 171 
the non-ESBL producers, respectively). The presence of blaESBL genes was confirmed and the 172 
genes were identified in 35 phenotypic ESBL producers as blaCTX-M-15 (n=17/48.6% of the 173 
blaESBLs), blaCTX-M-1 (n=10/28.6%), blaCTX-M-55 (n=4/11.4%), blaCTX-M-14 (n=3/8.6%), and 174 
blaCTX-M-27 (n=1/2.9%). Except for one blaCTX-M-1, all blaESBLs were detected in canine isolates. 175 
Overall, 51 (79.7%) of the isolates were resistant to nalidixic acid, and 47 thereof were 176 
ciprofloxacin resistant (Table 1 and supplementary Table S1). Among the isolates displaying 177 
ciprofloxacin resistance, all revealed chromosomal mutations that result in amino acid 178 
substitutions in GyrA and ParC (Table 2 and supplementary Table S1). The plasmid-mediated 179 
fluoroquinolone resistance genes aac(6')-Ib-cr and qnrB were detected in 17 (26.6% of all 180 
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isolates), and one (1.6%) isolate, respectively, and were restricted to canine isolates (Table 3 181 
and supplementary Table S1). The plasmid-mediated azithromycin resistance gene mph(A) 182 
was found in 13 (20.3%) of the isolates. The majority (n= 15/88.2%) of the 17 isolates with 183 
plasmid-mediated fluoroquinolone resistance and the majority (n= 34/69.4%) of the 49 184 
isolates with chromosomally mediated quinolone resistance were ESBL producers (Table 3). 185 
Only 4 (6.3%) isolates were non-drug resistant (NDR) (supplementary Table S1). 186 
 187 
3.2. Phylogenetic groups and ST  188 
 189 
As shown in Table 3, the most prevalent phylogenetic group was C (n=19 /29.7% of all 190 
isolates), followed by group B2 (n=15 /23.4%), B1 (n=10/15.6%), group A (n=9/14%), group 191 
F (n=8/12.5%), and group D (n=3/4.7%). None of the isolates belonged to phylogenetic group 192 
E or clade I. Among feline isolates, phylogenetic group B2 predominated (n=7 /53.8% of all 193 
feline isolates), whilst among canine isolates, the majority (n=18/35.3%) belonged to group C. 194 
MLST assigned the majority (n=39/60.9%) of the isolates to 9 different clonal complexes 195 
(CC): CC10 (n=3), CC12 (n=2), CC23 (n=17), CC73 (n=5) and CC131 (n=5), CC156 (n=1), 196 
CC354 (n=2), CC469 (n=1), and CC648 (n=3).  197 
Twenty-six different STs were identified, the three most common represented by ST410 198 
(n=16/25%), ST131, and ST73 (both n=5/7.8%). Less frequently occurring STs included 199 
ST533 (n=4/6.3%), and ST361, ST744 and ST648 (each n=3/4.7%, respectively). All other 200 
STs were represented by one or two isolates only (Table 3 and supplementary Table S1). 201 
Two new STs were detected, which however were not assigned numerical designations by the 202 
E. coli MLST database (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). Figure 1 illustrates 203 
eBURST showing relationships between the isolates. The prevalence of the most common ST, 204 
ST410, was variable, declining from 50% in 2012 to 1% in 2015, with an increase to 33.3% 205 
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observed for 2016. Of the 64 isolates, a total of 10 (15.6%) belonged STs frequently 206 
associated with human UTI (ST73 and ST131).  207 
The MDR, ESBL- and non-ESBL producers were distributed throughout phylogroups A, B1, 208 
B2, C, D and F. 209 
 210 
3.3. Distribution of VF genes 211 
 212 
Overall, 47 (73.4%) of the isolates tested positive for one or more of the VF genes (Table 3). 213 
Among the 64 isolates, the prevalence of individual VF genes was 53.1% for fyuA, 48.4% for 214 
traT, 34.4% for yfcv and PAI, 23.4% for hlyA, 20.3% for papAH, and 18.8% for papEF.  215 
The overall median aggregate VF score was highest for isolates belonging to phylogenetic 216 
group B2 (median aggregate VF score 6, mean score 5,5, range 3-7), followed by isolates 217 
from phylogenetic group F (3/ 2,9/1-4). Isolates assigned to phylogenetic group D scored 218 
2/2/2-2, and isolates of phylogenetic group A scored 1/1,8/ 0-6. The overall median aggregate 219 
VF scores were lowest for isolates belonging to phylogenetic group C (0/ 0.5/0-3).  220 
Among the most common STs in this study, ST131 harboured the highest number of VF 221 
(7/6,4/4-7), followed by ST73 (4/4,6/4-7), and ST648 (4/3,7/3-4). Of the most prevalent ST in 222 
this study, ST410 harboured the lowest number of VF (0/0,3/0-2). 223 
VF scores were higher in NDR (4/3.8/3-4) than in MDR (1/1,9/0-7), higher in non-ESBL 224 
producing isolates (3/3/0-7) than in ESBL producers (1/1,7/0-7), and higher in isolates that 225 
did not harbour mph(A) (2/2,6/0-7), than those that harboured mph(A) (1/1,1/0-4). 226 
 227 
4. Discussion 228 
 229 
In this study, we assessed antimicrobial resistance, phylogenetic background, and virulence 230 
profiles of ESBL producing, and non-ESBL producing UPEC isolated from cats and dogs 231 
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admitted to the veterinary clinic of the University of Zürich, Switzerland. In veterinary as in 232 
human medicine, antimicrobials are the cornerstone of treatment of bacterial UTI.  233 
Sulfamethoxazole/trimethoprim, amoxicillin/clavulanate, quinolones and chloramphenicol are 234 
antimicrobial compounds that are recommended for the treatment of feline and canine UTI 235 
due to infection with E. coli (Barsanti, 2012). Our data show that infection management may 236 
be compromised by the high rate of resistance to these drugs, similar to the situation /as 237 
described for UPEC in humans (Gibreel et al., 2012; Nicolle 2013; Nolan et al., 2015; 238 
Lavigne et al. 2016). Furthermore, of the 205 isolates from our strain collection, 35 (17%) 239 
were ESBL producers and the annual prevalence ranged from 9.9% to 35.3%. This is a 240 
remarkable increase compared to the prevalence of 7.5% ESBL producers among UPEC 241 
isolated from companion animals at our institution between 2010–2011 (Huber et al., 2013), 242 
and poses a threat to the efficacy of third-generation cephalosporins approved for use in 243 
veterinary medicine, such as cefovecin (Stegemann et al., 2006). Further, the high prevalences 244 
of 26.6% aac(6')-Ib-cr  and 13.6% mph(A) among the UPEC analysed in this study contrast 245 
noticeably with the 2.3% and 13.6%, respectively, observed for these genes in UPEC from 246 
human primary care patients in Switzerland (Nüesch-Inderbinen et al., 2017), and indicate 247 
that companion animals, particularly dogs, may serve as reservoirs for E. coli harbouring 248 
these resistance genes. 249 
In this study, we identified the phylogenetic groups based on the new Clermont method which 250 
enabled, besides the phylogenetic groups A, B1, B2, and D, the identification of groups C and 251 
F among the feline and canine UPEC. Our results show that in accordance to previous reports, 252 
UPEC isolates from cats frequently belonged to group B2 (Wagner et al., 2014; Liu et al., 253 
2015). However, overall, phylogroup C had the highest prevalence, a finding which is in 254 
contrast to previous studies of UPEC in animals as well as in humans that indicate the 255 
predominance of extraintestinal, pathogenic group B2 (Barsanti, 2012; Gibreel et al., 2012). 256 
Data on the prevalences of phylogroups C, E, F and clade I among UPEC are rare, but a 257 
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recent study shows that among human isolates, approximately 25% belong to these groups 258 
(Iranpour et al., 2015). Since 42.2% of the isolates belonged to the newly described 259 
phylogroups C and F, further studies are needed to provide a more refined understanding of 260 
the prevalences of phylogenetic groups among E. coli isolates of animal and human origin. 261 
Antimicrobial resistant as well as susceptible UPEC in humans are frequently associated with 262 
specific clonal complexes such as CC69, CC73, CC95, ST127, and CC131 (Lau et al., 2008; 263 
Gibreel et al., 2012). Some of these CCs or STs, such as CC73, ST127 and CC131 have also 264 
been described as etiological agents of UTI in companion animals (Johnson et al., 2008a; 265 
Johnson et al., 2009). Corresponding well with reports on human UPEC (Bengtsson et al., 266 
2012), we found 80% of the E. coli ST131 isolates to ESBL producers, and all of the ST73 267 
isolates to be non-ESBL producers. Overall, our data specified that 15.6% of UPEC from cats 268 
and dogs belong to STs commonly associated with UTI in humans and harbour urovirulence 269 
genes that are identical to those found in human isolates (Gibreel et al., 2012). Other STs 270 
found in this study, such as ST648 and ST410 are also associated with extraintestinal disease 271 
in humans and animals, but not specifically with UTI (Ewers et al., 2014; Falgenhauer et al. 272 
2016; Schaufler et al. 2016; Timofte et al., 2016). Therefore, although major UPEC clones 273 
described in human infection were not predominant, such strains exhibit reciprocal zoonotic 274 
potential, and should be considered a threat to pet owners and companion animals alike. 275 
The high prevalence of ST410 in ESBL-producing UPEC from dogs has been observed 276 
previously in Switzerland (Huber et al., 2013). This ST, assigned to phylogroup C, displayed 277 
inverse association of VF scores with MDR and with plasmid-mediated resistance to third-278 
generation beta-lactams, aminoglycosides and macrolides. This phenomenon was observed 279 
among other isolates belonging to phylogenetic groups A and C, suggesting that selective 280 
pressure, rather than virulence may be the driving force behind the high prevalence of ST410 281 
among canine UPEC. However, the panel of VFs selected for this study was limited in 282 
number and represents only a subset of known VFs. Other determinants of virulence may 283 
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have been missed that may have shown a different tendency. Nevertheless, the high 284 
prevalence of isolates belonging to phylogenetic groups A, B1 and C indicate that the 285 
commensal flora of companion animals may play an important role in the aetiology of UTI. 286 
The results of this study illustrate the need for further observation of E. coli causing disease in 287 
companion animals, as well as the prudent use of antimicrobials in veterinary medicine, 288 
including the use of third generation cephalosporins, fluoroquinolones and macrolides.  289 
 290 
5. Conclusion 291 
 292 
In conclusion, our findings showed that feline and canine UPEC population was characterized 293 
by a high prevalence of MDR. ESBLs producing UPEC were detected almost exclusively 294 
among canine isolates. Phylogenetic groups B2 and F were associated more frequently with 295 
VF than other groups. In this study, group C was the most predominant phylogenetic group 296 
and displayed the lowest number of VF. MLST revealed a diverse clonal structure, and 297 
detected STs that may pose an infectious threat to humans. The most frequent MLST was 298 
ST410, which was characterized by a high prevalence of plasmid-mediated resistance genes 299 
blaCTX-M-15, aac(6’)-Ib-cr and mph(A), and a low aggregate VF score.  300 
These results increase our current knowledge of the phenotypic and genotypic characteristics 301 
of feline and canine UPEC, and may be advantageous for future infection management and 302 
prevention. 303 
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Figure legend 441 
 442 
MLST-based eBURST diagram depicting non-ESBL and ESBL producing UPEC isolated 443 
from cats and dogs. Each ST is represented by a circle, the size of which correlates to the 444 
frequency of the ST. Pie parts represent the number of strains within one ST. Exact numbers 445 
of isolates per ST are given in Table 3 and supplementary Table S1. Black outer rings show 446 
percentage of dog-derived strains from dogs, white outer rings show percentage of strains 447 
from cats. Isolates that tested negative by PCR for blaESBL genes are coloured grey. Isolates 448 
harbouring blaCTX-M-1 are depicted in blue,blaCTX-M-14 in red, blaCTX-M-15 in orange, blaCTX-M-27 449 
in turquoise, blaCTX-M-55 in green. 450 
 451 
